Radiesse and Bioform Medical Inc. recently announced that one million syringes of Radiesse dermal filler have been shipped worldwide since 2002.
Radiesse is Bioform’s most popular product and most commonly used to fill wrinkles, nasolabial folds and restore facial volume.
Radiesse has been marketed for cosmetic and therapeutic use in Europe since 2002. In 2006 FDA approval for subdermal implantation in aesthetic facial treatments was granted in the United States, expanding Radiesse’ use beyond therapeutic treatments.
At this point, approximately ten-thousand practices have used Radiesse, an achievement that solidifies the company’s position as one of the international market leaders. The only comparable products with such widespread appeal are fillers composed of collagen or hyaluronic acid, both of which have been on the market longer.
To read more about Radiesse, see our Radiesse page on the Skin Speaks website here.
